Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5 Methyluracil
2. 5-methyluracil
1. 5-methyluracil
2. 65-71-4
3. 2,4-dihydroxy-5-methylpyrimidine
4. Thymin
5. 5-methylpyrimidine-2,4(1h,3h)-dione
6. Thymine Anhydrate
7. 2,4(1h,3h)-pyrimidinedione, 5-methyl-
8. 5-methyl-2,4(1h,3h)-pyrimidinedione
9. Thymin (purine Base)
10. 5-methyl-1h-pyrimidine-2,4-dione
11. 5-methyl Uracil
12. 5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
13. Ccris 5584
14. 5-methylpyrimidine-2,4-diol
15. 5-methylpyrimidine-2,4-dione
16. 4-hydroxy-5-methylpyrimidin-2(1h)-one
17. Chebi:17821
18. Ai3-25479
19. Nsc14705
20. Mfcd00006026
21. Qr26ylt7lt
22. Chembl993
23. Zidovudine Related Compound C
24. 5-methyl-2,4-dihydroxypyrimidine
25. Nsc-14705
26. 123430-67-1
27. 153445-43-3
28. 5-methylpyrimidine-2,4(1h,3h)-dione (thymine)
29. Thy
30. Thymine-t
31. Thymine (van)
32. (3h)methylthymidine
33. Methyl-3h Thymidine
34. Thymine (8ci)
35. Nsc-168663
36. 5-methy Uracil(thymine)
37. Einecs 200-616-1
38. Unii-qr26ylt7lt
39. Nsc 14705
40. 5-methyl-uracil
41. Thymine,(s)
42. Thymine [inci]
43. Thymine, >=99%
44. Thymine [mi]
45. Zidovudine Ep Impurity C
46. Thymine [who-dd]
47. Epitope Id:167476
48. Schembl5235
49. Dsstox_cid_30914
50. Dsstox_gsid_52342
51. 2,4(1h,3h)-pyrimidinedione, 5-methyl- (9ci)
52. 4(1h)-pyrimidinone, 2-hydroxy-5-methyl- (9ci)
53. 4(3h)-pyrimidinone, 2-hydroxy-5-methyl- (9ci)
54. 5-methyl-2,4-dioxypyrimidine
55. Thymine [usp Impurity]
56. 2.6-dioxy-5-methyl-pyrimidin
57. Gtpl4581
58. Dtxsid4052342
59. Schembl15496760
60. Schembl16356870
61. Wln: T6n Cnj Bq Dq E1
62. 2,4(1h,3h)-pyrimidinedione, 5-methyl-, Labeled With Tritium
63. Zinc157062
64. Bcp22973
65. 2,3h)-pyrimidinedione, 5-methyl-
66. Tox21_303929
67. Bdbm50134397
68. S9382
69. Stl280241
70. Stl477641
71. Stavuine Impurity A [who-ip]
72. Akos000120923
73. Akos002337369
74. Ac-7756
75. Am81332
76. Ccg-266101
77. Cs-w011166
78. Db03462
79. Hy-w010450
80. Sb57778
81. Zidovudine Impurity C [who-ip]
82. Cas-65-71-4
83. Cid 5274265
84. Ncgc00357169-01
85. 2792-47-4
86. Sy014896
87. Thymine, Vetec(tm) Reagent Grade, 99%
88. Db-016098
89. Zidovudine Impurity C [ep Impurity]
90. Ft-0602550
91. Ft-0675207
92. Ft-0771534
93. T0234
94. C00178
95. T-3845
96. Thymine, Suitable For Cell Culture, Bioreagent
97. Zidovudine Related Compound C [usp-rs]
98. 006t026
99. A835203
100. Q171973
101. Sr-01000945223
102. Sr-01000945223-1
103. Zidovudine Related Compound C [usp Impurity]
104. 036b9f1d-9b61-4ced-967c-bf1da180e5c2
105. F0001-1753
106. Zidovudine Related Compound C, United States Pharmacopeia (usp) Reference Standard
107. 3059-73-2
108. Thymine(zidovudine Related Compound C), Pharmaceutical Secondary Standard; Certified Reference Material
109. Thymine; Usp Zidovudine Related Compound C; 5-methyluracil; 5-methylpyrimidine-2,4(1h,3h)-dione; 4-hydroxy-5-methylyrimidin-2(1h)-one
| Molecular Weight | 126.11 g/mol |
|---|---|
| Molecular Formula | C5H6N2O2 |
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 126.042927438 g/mol |
| Monoisotopic Mass | 126.042927438 g/mol |
| Topological Polar Surface Area | 58.2 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 195 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A CAS-65-71-4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-65-71-4, including repackagers and relabelers. The FDA regulates CAS-65-71-4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-65-71-4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-65-71-4 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-65-71-4 supplier is an individual or a company that provides CAS-65-71-4 active pharmaceutical ingredient (API) or CAS-65-71-4 finished formulations upon request. The CAS-65-71-4 suppliers may include CAS-65-71-4 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-65-71-4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
CAS-65-71-4 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-65-71-4 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-65-71-4 GMP manufacturer or CAS-65-71-4 GMP API supplier for your needs.
A CAS-65-71-4 CoA (Certificate of Analysis) is a formal document that attests to CAS-65-71-4's compliance with CAS-65-71-4 specifications and serves as a tool for batch-level quality control.
CAS-65-71-4 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-65-71-4 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-65-71-4 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-65-71-4 EP), CAS-65-71-4 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-65-71-4 USP).
LOOKING FOR A SUPPLIER?
